Cover Image
市場調查報告書

數位病理學的全球市場預測 2021年:掃描機、軟體、通信系統、存儲系統

Digital Pathology Market by Product (Scanners, Software), Type (Human, Animal Pathology), End User (Pharmaceutical Company, Hospital, Academic Institutions), Application (Teleconsultation, Drug Discovery) - Global Forecasts to 2021

出版商 MarketsandMarkets 商品編碼 251934
出版日期 內容資訊 英文 154 Pages
訂單完成後即時交付
價格
Back to Top
數位病理學的全球市場預測 2021年:掃描機、軟體、通信系統、存儲系統 Digital Pathology Market by Product (Scanners, Software), Type (Human, Animal Pathology), End User (Pharmaceutical Company, Hospital, Academic Institutions), Application (Teleconsultation, Drug Discovery) - Global Forecasts to 2021
出版日期: 2016年05月31日 內容資訊: 英文 154 Pages
簡介

全球數位病理學市場規模,預計從2016年到2021年以12.1%的年複合成長率發展,從2016年的3億8,430萬美元到2021年達到6億7,910萬美元。預計在2016年的該市場中,各產品中以掃描機區分,各地區中以北美構成最大的佔有率。

本報告以全球數位病理學市場為主題,提供各市場概要、趨勢概要,類型、終端用戶、應用、地區的市場分析、預測,競爭情形分析,及主要企業簡介等資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 數位病理學市場概要
  • 數位病理學市場地區分析
  • 數位病理學市場:各類型
  • 數位病理學市場:各終端用戶
  • 數位病理學市場:各應用領域
  • 數位病理學市場地區概要

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 促進要素
    • 阻礙要素
    • 機會
  • 法律規範

第6章 數位病理學市場:各產品

  • 簡介
  • 掃描機
  • 軟體
  • 通信系統
  • 存儲系統

第7章 數位病理學市場:各類型

  • 簡介
  • 人體數位病理學
  • 動物數位病理學

第8章 數位病理學市場:各終端用戶

  • 簡介
  • 醫藥品、生物科技企業及CRO
  • 醫院及參考檢驗室
  • 大學、政府研究機關

第9章 數位病理學市場:各應用領域

  • 簡介
  • 遠程醫療諮詢
  • 病的診斷
  • 藥物研發
  • 訓練、教育

第10章 全球數位病理學市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區(ROW)

第11章 競爭環境

  • 概要
  • 競爭情形、趨勢

第12章 企業簡介

  • 簡介
  • LEICA BIOSYSTEMS NUSSLOCH GMBH (SUBSIDIARY OF DANAHER CORP)
  • VENTANA MEDICAL SYSTEMS, INC. (MEMBER OF ROCHE GROUP)
  • HAMAMATSU PHOTONICS K.K.
  • 3DHISTECH LTD.
  • PHILIPS HEALTHCARE
  • APOLLO ENTERPRISE IMAGING CORP. (FORMERLY APOLLO PACS, INC.) 1
  • XIFIN, INC.
  • DEFINIENS AG
  • VISIOPHARM A/S
  • OMNYX, LLC (VENTURE BY GE HEALTHCARE AND UPMC)
  • CORISTA LLC

第13章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HIT 2608

The digital pathology market is poised to reach USD 679.1 million by 2021 from USD 384.3 million in 2016, growing at a CAGR of 12.1% during the forecast period of 2016 to 2021.

Digital pathology is an image-based information environment that allows for the management of information generated from a digital slide. The growth of the overall digital pathology market can be contributed to the rising prevalence of chronic diseases, utilization of digital pathology for drug discovery and companion diagnostics, and growing initiatives by government and industry player's to enhance pathological services.

The scanners segment is expected to account for the largest share of the digital pathology market, by product, in 2016. Digital pathology scanners create whole-slide images (WSI) from glass slides, converting the images into a digital form which helps to view, analyze, manage, share, and store them easily and efficiently, thus attributing to the largest share of the market. The human pathology segment is expected to account for the largest share of the digital pathology market, by type, in 2016. The large share of this segment is mainly due to increasing utilization of digital pathology for chronic disease diagnosis. The pharmaceutical & biotechnology companies and CROs is expected to account for the largest share of the global digital pathology market, end user, in 2016. Pharmaceutical and biotechnology companies are using digital pathology in drug discovery and companion diagnostics, thus contributing to the largest share of this market. The teleconsultation segment is estimated to account for the largest share of the digital pathology market, by application, in 2016. Increasing demand for pathology consultation in underserved areas through telepathology attributes to growth of this application.

North America is expected to account for the largest share of the global digital pathology market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The large share of the North American region can be attributed to the presence of major pharmaceutical companies, increased cancer prevalence, presence of top market players, and growing government initiatives in Canada. The Asia-Pacific region is expected to witness the highest growth rate in the forecast period, mainly due to the growing chronic diseases prevalence, entry of top players and less stringent regulations in field of diagnostics.

The digital pathology market witnesses high competitive intensity, as there are several big and small firms with similar product offerings. These companies adopt various strategies (partnerships, joint ventures, collaborations, expansions, new product launches, and acquisition) to increase their market shares and establish a stronger foothold in the global market. Prominent players in the global digital pathology market are Leica Biosystems Nussloch GMBH (Germany), Ventana Medical Systems, Inc.(U.S.), Hamamatsu Photonics K.K (Japan), 3D Histech Ltd(Hungary)., Philips Healthcare (Netherlands), Apollo Enterprise Imaging Corp.(U.S.), Xifin, Inc.(U.S.), Definiens AG (Germany), Visiopharm A/S (Denmark), Omnyx, LLC.(U.S.), Corista LLC (U.S.).

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the digital pathology market. The report analyzes the market based on type, application, therapeutic area, and end user
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the digital pathology market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various digital pathology products across regions.
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the digital pathology market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the digital pathology market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key data from primary sources
      • 2.2.2.2. Key insights from primary sources
      • 2.2.2.3. Key industry insights
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. RESEARCH DESIGN
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. OVERVIEW OF THE DIGITAL PATHOLOGY MARKET
  • 4.2. GEOGRAPHIC ANALYSIS OF THE DIGITAL PATHOLOGY MARKET
  • 4.3. DIGITAL PATHOLOGY MARKET, BY TYPE
  • 4.4. DIGITAL PATHOLOGY MARKET, BY END USER
  • 4.5. DIGITAL PATHOLOGY MARKET, BY APPLICATION
  • 4.6. GEOGRAPHIC SNAPSHOT OF THE DIGITAL PATHOLOGY MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Rising prevalence of cancer
      • 5.3.1.2. Increasing adoption of digital pathology to enhance lab efficiency
      • 5.3.1.3. Growing application of digital pathology in drug development and companion diagnostics
      • 5.3.1.4. Ease of consultation enabled by digital pathology
      • 5.3.1.5. Increasing initiatives by governments and industry players
      • 5.3.1.6. Increasing number of research projects establishing the efficacy of digital pathology
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. High cost of digital pathology systems
      • 5.3.2.2. Regulatory concerns
      • 5.3.2.3. Lack of standard guidelines
      • 5.3.2.4. Reluctance among pathologists to adopt advanced technologies
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Digital pathology to help combat the shortage of pathologists
      • 5.3.3.2. Introduction of affordable scanners for private pathology practices
      • 5.3.3.3. Personalized medicine to open array of opportunities
      • 5.3.3.4. Integration of laboratory information systems (LIS) and digital pathology systems
      • 5.3.3.5. Increasing digital pathology initiatives in Asia
  • 5.4. REGULATORY IMPLICATIONS
    • 5.4.1. HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT (HIPAA)
    • 5.4.2. FOOD AND DRUG ADMINISTRATION (FDA)
    • 5.4.3. CLINICAL LABORATORY IMPROVEMENT AMENDMENTS (CLIA)

6. DIGITAL PATHOLOGY MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. SCANNERS
  • 6.3. SOFTWARE
  • 6.4. COMMUNICATION SYSTEMS
  • 6.5. STORAGE SYSTEMS

7. DIGITAL PATHOLOGY MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. HUMAN DIGITAL PATHOLOGY
  • 7.3. ANIMAL DIGITAL PATHOLOGY

8. DIGITAL PATHOLOGY MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CRO'S
  • 8.3. HOSPITALS AND REFERENCE LABORATORIES
  • 8.4. ACADEMIC & GOVERNMENT RESEARCH INSTITUTES

9. DIGITAL PATHOLOGY MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. TELECONSULTATION
  • 9.3. DISEASE DIAGNOSIS
  • 9.4. DRUG DISCOVERY
  • 9.5. TRAINING AND EDUCATION

10. GLOBAL DIGITAL PATHOLOGY MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
      • 10.2.1.1. Favorable reimbursement scenario for digital pathology in the U.S.
      • 10.2.1.2. Rising cancer prevalence in the U.S.
      • 10.2.1.3. De Novo application by the FDA
    • 10.2.2. CANADA
      • 10.2.2.1. Growing need for quality cancer diagnosis in Canada
      • 10.2.2.2. Implementation of favorable initiatives by Canadian authorities
  • 10.3. EUROPE
    • 10.3.1. EU-5
      • 10.3.1.1. Initiatives adopted by NHS England promoting the adoption of digital pathology in the U.K.
      • 10.3.1.2. Technological developments in the U.K. market
      • 10.3.1.3. Organization of digital pathology-related conferences in the U.K.
      • 10.3.1.4. Organization of digital pathology-related conferences in Germany
      • 10.3.1.5. Successful digital pathology projects in Italy
      • 10.3.1.6. Active involvement of industry players to augment the demand for digital pathology in France
      • 10.3.1.7. Implementation of digital pathology-related projects to drive market growth in Spain
    • 10.3.2. ROE
      • 10.3.2.1. High cancer prevalence to boost market growth in Denmark
      • 10.3.2.2. Norway: Conferences and industry collaborations in the regional market
      • 10.3.2.3. Increased investments by government bodies in Sweden
      • 10.3.2.4. Digital pathology gaining momentum in the Netherlands
  • 10.4. ASIA-PACIFIC
    • 10.4.1. CHINA
      • 10.4.1.1. Industry initiatives to boost digital pathology market in China
      • 10.4.1.2. Favorable initiatives for the adoption of telepathology in China
    • 10.4.2. JAPAN
      • 10.4.2.1. Initiatives by NEC for cancer diagnosis to propel the market in Japan
    • 10.4.3. INDIA
      • 10.4.3.1. Focus of market players on India
    • 10.4.4. ROAPAC
      • 10.4.4.1. Cancer control initiatives in Australia
      • 10.4.4.2. Approvals for digital pathology solutions in South Korea, partnerships between local and global players
  • 10.5. ROW
    • 10.5.1. POTENTIAL FOR THE GROWTH OF DIGITAL PATHOLOGY IN AFRICA
    • 10.5.2. INCREASING FOCUS BY INDUSTRY PLAYERS AND ACADEMIC INSTITUTES ON THE BRAZILIAN MARKET
    • 10.5.3. INCREASING FOCUS OF INDUSTRY PLAYERS ON ORGANIC GROWTH STRATEGIES IN THE MIDDLE EAST

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. COMPETITIVE SITUATION AND TRENDS
    • 11.2.1. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 11.2.2. PRODUCT LAUNCHES
    • 11.2.3. CLIENT ACQUISITIONS
    • 11.2.4. EXPANSIONS
    • 11.2.5. ACQUISITIONS
    • 11.2.6. OTHER STRATEGIES

12. COMPANY PROFILES (Overview, Financial*, Products & Services, Strategy, and Developments)

  • 12.1. INTRODUCTION
  • 12.2. LEICA BIOSYSTEMS NUSSLOCH GMBH (SUBSIDIARY OF DANAHER CORP)
  • 12.3. VENTANA MEDICAL SYSTEMS, INC. (MEMBER OF ROCHE GROUP)
  • 12.4. HAMAMATSU PHOTONICS K.K.
  • 12.5. 3DHISTECH LTD.
  • 12.6. PHILIPS HEALTHCARE
  • 12.7. APOLLO ENTERPRISE IMAGING CORP. (FORMERLY APOLLO PACS, INC.)
  • 12.8. XIFIN, INC.
  • 12.9. DEFINIENS AG
  • 12.10. VISIOPHARM A/S
  • 12.11. OMNYX, LLC (VENTURE BY GE HEALTHCARE AND UPMC)
  • 12.12. CORISTA LLC

*Details might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. COMPANY DEVELOPMENTS (2013-2016)
    • 13.3.1. LEICA BIOSYSTEMS NUSSLOCH GMBH (A SUBSIDIARY OF DANAHER CORP)
    • 13.3.2. VENTANA MEDICAL SYSTEMS, INC. (A MEMBER OF ROCHE GROUP)
    • 13.3.3. PHILIPS HEALTHCARE
    • 13.3.4. APOLLO ENTERPRISE IMAGING CORP. (FORMERLY APOLLO PACS, INC.)
    • 13.3.5. DEFINIENS AG
    • 13.3.6. VISIOPHARM A/S
    • 13.3.7. OMNYX, LLC (A VENTURE BY GE HEALTHCARE AND UPMC)
  • 13.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.6. AVAILABLE CUSTOMIZATIONS
  • 13.7. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 2: DIGITAL PATHOLOGY SCANNERS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 3: DIGITAL PATHOLOGY SCANNERS VOLUME SOLD, BY REGION, 2014-2021
  • TABLE 4: TYPES OF DIGITAL PATHOLOGY SOFTWARE
  • TABLE 5: DIGITAL PATHOLOGY SOFTWARE MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 6: COMMUNICATION SYSTEMS USED IN DIGITAL PATHOLOGY
  • TABLE 7: DIGITAL PATHOLOGY COMMUNICATION SYSTEMS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 8: DIGITAL PATHOLOGY STORAGE SYSTEMS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 9: GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 10: HUMAN DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 11: ANIMAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY/ REGION, 2014-2021 (USD MILLION)
  • TABLE 12: GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 13: GLOBAL DIGITAL PATHOLOGY MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES & CROS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 14: GLOBAL DIGITAL PATHOLOGY MARKET SIZE FOR HOSPITALS AND REFERENCE LABORATORIES, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 15: GLOBAL DIGITAL PATHOLOGY MARKET SIZE FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 16: GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 17: GLOBAL DIGITAL PATHOLOGY MARKET SIZE FOR TELECONSULTATION, BY REGION/COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 18: GLOBAL DIGITAL PATHOLOGY MARKET SIZE FOR DISEASE DIAGNOSIS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 19: GLOBAL DIGITAL PATHOLOGY MARKET SIZE FOR DRUG DISCOVERY, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 20: GLOBAL DIGITAL PATHOLOGY MARKET SIZE FOR TRAINING AND EDUCATION, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 21: DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: NORTH AMERICA: DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 23: NORTH AMERICA: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 24: NORTH AMERICA: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 25: NORTH AMERICA: DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 26: NORTH AMERICA: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 27: U.S.: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 28: U.S.: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 29: U.S.: DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 30: U.S.: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 31: CANADA: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 32: CANADA: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 33: CANADA: DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 34: CANADA: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 35: EUROPE: DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: EUROPE: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 37: EUROPE: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 38: EUROPE: DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 39: EUROPE: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 40: EU-5: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 41: EU-5: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 42: EU-5: DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 43: EU-5: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 44: ROE: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 45: ROE: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 46: ROE: DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 47: ROE: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 48: ASIA-PACIFIC: DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 49: ASIA-PACIFIC: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 50: ASIA-PACIFIC: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 51: ASIA-PACIFIC: DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 52: ASIA-PACIFIC: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 53: CHINA: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 54: CHINA: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 55: CHINA: DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 56: CHINA: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 57: JAPAN: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 58: JAPAN: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 59: JAPAN: DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 60: JAPAN: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 61: INDIA: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 62: INDIA: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 63: INDIA: DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 64: INDIA: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 65: ROAPAC: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 66: ROAPAC: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 67: ROAPAC: DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 68: ROAPAC: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 69: ROW: DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 70: ROW: DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 71: ROW: DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 72: ROW: DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 73: RECENT DEVELOPMENTS, 2013-2016
  • TABLE 74: RECENT DEVELOPMENTS, 2013-2016
  • TABLE 75: RECENT DEVELOPMENTS, 2013-2016
  • TABLE 76: RECENT DEVELOPMENTS, 2013-2016
  • TABLE 77: RECENT DEVELOPMENTS, 2013-2016
  • TABLE 78: RECENT DEVELOPMENTS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL DIGITAL PATHOLOGY MARKET SEGMENTATION
  • FIGURE 2: GLOBAL DIGITAL PATHOLOGY MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: GLOBAL DIGITAL PATHOLOGY MARKET ANALYSIS, BY PRODUCT (2016)
  • FIGURE 8: GLOBAL DIGITAL PATHOLOGY MARKET ANALYSIS, BY TYPE, 2016 VS. 2021
  • FIGURE 9: GLOBAL DIGITAL PATHOLOGY MARKET ANALYSIS, BY END USER, 2016 VS. 2021
  • FIGURE 10: GLOBAL DIGITAL PATHOLOGY MARKET ANALYSIS, BY APPLICATION (2016)
  • FIGURE 11: ASIA-PACIFIC MARKET TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 12: ATTRACTIVE OPPORTUNITIES IN THE DIGITAL PATHOLOGY MARKET
  • FIGURE 13: NORTH AMERICA TO DOMINATE THE DIGITAL PATHOLOGY MARKET
  • FIGURE 14: HUMAN PATHOLOGY SEGMENT TO GROW AT THE HIGHEST RATE
  • FIGURE 15: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CRO'S SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 16: TELECONSULTATION SEGMENT WILL COMMAND THE LARGEST SHARE OF THE MARKET IN 2021
  • FIGURE 17: ASIA-PACIFIC TO REGISTER HIGHEST GROWTH RATE FROM 2016 TO 2021
  • FIGURE 18: GLOBAL DIGITAL PATHOLOGY MARKET SEGMENTATION
  • FIGURE 19: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 20: DIGITAL PATHOLOGY MARKET SEGMENTATION, BY PRODUCT
  • FIGURE 21: GLOBAL DIGITAL PATHOLOGY MARKET, BY TYPE, 2016-2021
  • FIGURE 22: DIGITAL PATHOLOGY MARKET SEGMENTATION, BY END USER
  • FIGURE 23: TELECONSULTATION TO COMMAND LARGEST SHARE OF THE DIGITAL PATHOLOGY MARKET, BY APPLICATION
  • FIGURE 24: DIGITAL PATHOLOGY MARKET, BY REGION, 2016
  • FIGURE 25: NORTH AMERICA: DIGITAL PATHOLOGY MARKET SNAPSHOT
  • FIGURE 26: EUROPE: DIGITAL PATHOLOGY MARKET SNAPSHOT
  • FIGURE 27: ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SNAPSHOT
  • FIGURE 28: ROW DIGITAL PATHOLOGY MARKET SNAPSHOT
  • FIGURE 29: FIGURE: GROWTH STRATEGIES, BY COMPANY
  • FIGURE 30: ACQUISITIONS & EXPANSIONS WERE THE KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS
  • FIGURE 31: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, BY COMPANY (2013-2016)
  • FIGURE 32: PRODUCT LAUNCHES, BY COMPANY (2013-2016)
  • FIGURE 33: CLIENT ACQUISITIONS, BY COMPANY (2013-2016)
  • FIGURE 34: EXPANSIONS, BY COMPANY (2013-2016)
  • FIGURE 35: ACQUISITIONS, BY COMPANY (2013-2016)
  • FIGURE 36: OTHER STRATEGIES, BY COMPANY (2013-2016)
  • FIGURE 37: PRODUCTS AND SERVICES OFFERED BY COMPANIES
  • FIGURE 38: DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 39: ROCHE GROUP: COMPANY SNAPSHOT
  • FIGURE 40: HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT
  • FIGURE 41: PHILIPS HEALTHCARE: COMPANY SNAPSHOT
Back to Top